Zaloguj Zarejestruj się zadarmo

Akari Therapeutics Plc organizacji Wskaźnik krótkiej sprzedaży

Jaka jest wartość Wskaźnik krótkiej sprzedaży organizacji Akari Therapeutics Plc?

Wartość Wskaźnik krótkiej sprzedaży organizacji Akari Therapeutics Plc to 0.65

Jaka jest definicja Wskaźnik krótkiej sprzedaży?



Wskaźnik krótkiej sprzedaży (Short ratio) to liczba akcji sprzedanych na krótko podzielona przez średnią wartość dzienną.

Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.

The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.

Wskaźnik krótkiej sprzedaży firm w Health Care sektor na NASDAQ w porównaniu do Akari Therapeutics Plc

Czym się zajmuję organizacja Akari Therapeutics Plc?

akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. akari’s lead drug, coversin, a second-generation and potentially best-in-class complement inhibitor, acts on complement component-c5, preventing release of c5a and formation of c5b – 9 (also known as the membrane attack complex or mac). coversin is a recombinant small protein (16,740 da) derived from a native protein discovered in the saliva of the ornithodoros moubata tick, where it modulates the host immune system to allow the parasite to feed without alerting the host to its presence or provoking an immune response.

Firmy z wskaźnik krótkiej sprzedaży podobne do Akari Therapeutics Plc